Lilly, Bracknell

Confidential

Rationalisation of the client’s European operation has created the need for this large pharmaceutical company to expand its existing UK research and development site facilities. In addition to masterplanning and carrying out the strategic design analysis for the project, a new two-storey, 2,300 sq m (24,757 sq ft) research office building has been created. The building incorporates a new communal hub and is situated between the existing campus laboratories and office facilities. The building has been designed to be low carbon in operation, with an innovative mixed mode active stack ventilation strategy.

+ +